Aralez Pharmaceuticals Inc. (TSE:ARZ – Get Free Report)’s share price traded up 10.3% during trading on Monday . The company traded as high as C$0.51 and last traded at C$0.43. 274,400 shares changed hands during mid-day trading, an increase of 247% from the average session volume of 79,103 shares. The stock had previously closed at C$0.39.
Aralez Pharmaceuticals Stock Up 10.3 %
The stock has a fifty day simple moving average of C$0.43.
Aralez Pharmaceuticals Company Profile
Aralez Pharmaceuticals Inc operates as a specialty pharmaceutical company in the United States and Canada. It engages in acquiring, developing, and commercializing products in the areas of cardiovascular, pain management, dermatological allergy, and other indications. It offers Zontivity for the reduction of thrombotic cardiovascular events in patients with heart attack or peripheral arterial disease; Toprol-XL, a cardioselective beta-blocker that is indicated for the treatment of hypertension; Fibricor, a fenofibric acid for the treatment of severe hypertriglyceridemia and patients with primary hypercholesterolemia or mixed dyslipidemia; and Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticarial.
Further Reading
- Five stocks we like better than Aralez Pharmaceuticals
- 5 Top Rated Dividend Stocks to Consider
- The Charles Schwab Company Can Hit New Highs
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- What is a Secondary Public Offering? What Investors Need to Know
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for Aralez Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.